Cardinal Health (NYSE:CAH – Free Report) had its price objective hoisted by JPMorgan Chase & Co. from $132.00 to $142.00 in a ...

In a report released yesterday, Stephen Baxter from Wells Fargo maintained a Hold rating on Cardinal Health (CAH – Research Report), with a ...

Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

Dublin City Schools is withdrawing from an agreement to buy Cardinal Health’s headquarters for $37 million to serve as a high ...

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals ...

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

Dublin City Schools is officially withdrawing from an agreement with Cardinal Health to purchase a vacant office building, Superintendent John Marschhausen told board members at a meeting Monday ...

Cardinal Health gets downgraded to a hold, from my buy rating last February, agreeing with the Seeking Alpha quant system rating. While macro-level demand for medical supplies is expected to keep ...

Cardinal Health Inc (NYSE:CAH). shares have reached an unprecedented peak, with the stock hitting an all-time high of $130.1.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

The Healthcare Distribution market has been expanding significantly in recent years, driven by various key factors like increased demand for its products, expanding customer base, and ...